Artificial Intelligence-based Biomarkers of Ageing
NUS Healthy Longevity webinar with Alex Zhavoronkov - CEO of Insilico Medicine
Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine (insilico.com), a leader in next-generation artificial intelligence technologies for drug discovery, biomarker development. He is also the founder and CEO of Deep Longevity, Inc, a global company developing a broad range of artificial intelligence-based biomarkers of ageing and longevity. Since 2015 he invented critical technologies in the field of generative adversarial networks (GANs) and reinforcement learning (RL) for generation of the novel molecular structures with the desired properties and generation of synthetic biological and patient data. He also pioneered the applications of deep learning technologies for prediction of human biological age using multiple data types, transfer learning from ageing into disease, target identification, and signaling pathway modeling.
Hosted by Prof Brian Kennedy.
11am UK time
See also: National University of Singapore (NUS) - Asia’s leading university with a global approach in education, research and service.
Interested in more events? View the club's event calendar.
Mentioned in this Resource
CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation.
Prof of Biochemistry and Physiology at NUS. CSO Ponce De Leon Health.